Elon Musk’s Neuralink Corp gets nod to begin human trials
HQ Team September 20, 2023: Elon Musk’s Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team September 20, 2023: Elon Musk’s Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a.
HQ Team September 20, 2023: Boston Scientific has acquired privately-held Relievant Medsystems, for more than $850 million to expand into the chronic low.
GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.
HQ Team September 19, 2023: More than half of the world’s population is still not covered by essential health services, and two billion.
HQ Team September 19, 2023: More than 1,000 people globally die of strokes and heart attacks every hour, mostly due to high blood.
HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.
HQ Team September 19, 2023: The USFDA stated that Accord Healthcare Inc.’s generic tacrolimus oral capsules, meant to treat organ rejection, were no.
HQ Team September 18, 2023: The Bill & Melinda Gates Foundation has given a grant of $44 million to GE Healthcare to create.
HQ Team September 18, 2023: German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic.
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency.